Abstract
The crude extract ofStreptomyces sp. strain KM86-9B, isolated from a marine sponge, displayed significant inhibition on topoisomerase I activity. Investigation of the causative components by bioactivity-directed fractionation resulted in the isolation of a series of iso- and anteiso-fatty acids.
Similar content being viewed by others
References Cited
Andoh, T., Ikeda, H., Oguro, M., Molecular biology of DNA topoisomerases and its application to chemotherapy-Proceedings of the International Symposium on DNA Topoisomerases in Chemotherapy, Nagoya, Japan, November 18–20, CRC Press, Boca Raton (1991).
Bae, M.-A., Tsuji, T., Kondo, K., Hirase, T., Ishibashi, M., Shigemori, H., Kobayashi, J., Inhibition of mamalian topoisomerase I by xestoquinone and halenaquinone.Biosci. Biotech. Biochem., 57, 330–331 (1993).
Bastow, K. F., Bori, I. D., Fukushima, Y., Kashiwada, Y., Tanaka, T., Nonaka, G., Nishioka, I., Lee, K. H., Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin fromSanguisorba officinalis.Planta Med., 59, 240–245 (1993).
Berry, D. E., Chan, J. A., MacKenzie, L., Hecht, S. M., 9-Octadecynoic acid; a novel DNA binding agent.Chem. Res. Toxicol., 4, 195–198 (1991).
Berry, D. E., MacKenzie, L., Shultis, E. A. and Chan. J. A., Naturally occurring inhibitors of topoisomerase I mediated DNA relaxation.J. Org. Chem., 57, 420–422 (1992).
Boege, F., Straub, T., Kehr, A., Boesenberg, C., Christiansen, K., Andersen, A., Jakob, F., Khrle, J., Selected novel flavones inhibit the DNA binding or DNA religation step of eukaryotic topoisomerse I.J. Biol. Chem., 271, 2261–2270 (1996).
Carney, J. R., Scheuer, P. J., Kelly-Borges, M., Makaluvamine G, a cytotoxic pigment from an Indonesian spongeHistodermella sp..Tetrahedron, 49, 8483–8486 (1993).
Chen, A. Y., Liu, L. F., DNA topoisomerases: Essential enzymes and lethal targets.Annu. Rev. Pharmacol. Toxicol., 34, 191–218 (1994).
D’arpa, P. and Liu, L. F., Topoisomerase-targeting antitumor drugs.Biochim. Biophys. Acta, 989, 163–177 (1989).
Dunn, C. D. R.,Scrips 1994 reviews of cancer chemotherapy. Chap. 4. New hopes in cancer chemotheraphy. PJB Publications Ltd. pp 129–209 (1994).
Giovanella, B. C., Stehlin, J. S., Wall, M. E., Wani, M. C., Nicholas, A. W., Liu, L. F., Silber, R., and Potmesil, M., DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts.Science, 246, 1046 (1989).
Jung, J. H., Lee, H., and Kang, S. S., Diacylglyceryl-galactosides fromArisaema amurense.Phytochemistry, 42, 447–452 (1996).
Kobayashi, J., Ishida, K., Naitoh, K., Shigemori, H., Xestokerols A, B, and C, new C29 steroids with a cyclopropane ring from the Okinawan marine spongeXestospongia sp..J. Nat. Prod., 56, 1350–1355 (1993).
Kobayashi, M., Okamoto, T., Hayashi, K., Yokoyama, N., Sasaki, T., and Kitagawa, I., Marine natural products XXXII. Absolute configurations of C-4 of the monoalide family, biologically active sesterterpenes from the marine spongeHyrtios erecta.Chem. Pharm. Bull., 42, 265–270 (1994).
Larsen, A. K., Grondard, L., Couprie, J., Desoize, B., Comoe, L., Jardiller, J. C., Riou, J. F., The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerase I and II.Biochem. Pharmacol., 46, 1403–1412 (1993).
Lechevalier, H. A. A practical guide to generic identification of Actinomycetes. InBergey’s Manual of Systematic Bateriology. vol. 4. eds. S.J. Williams, M. E. Sharpe, J. G. Holt. pp. 2344–2347. Williams and Wilkins Press, Baltimore. (1989).
Lee, D.-S., Hong, S.-D., Inhibition of DNA topoisomerase I by cryptotanshinone fromSalvia miltiorrhiza.J. Microbiol. Biotechnol., 8, 89–91 (1998).
Li, C. J., Averboukh, L., and Pardee, A. B., β-Lapachone, a novel DNA topoisomerse I inhibitor with a mode of action different from camptothecin.J. Biol. Chem., 268, 22463–22468 (1993).
Mizushima, T., Natori, S., and Sekimizu, K., Inhibition ofEscherichia coli DNA topoisomerase I activity by phospholipids.Biochem. J., 285, 503–506 (1992).
Omura, S., Nakagawa, A., Fukamachi, N., Otoguro, K., Kobayashi, B., Aggreceride, a new platelet aggregation inhibitor fromStreptomyces.J. Antibiot., 39, 1180–1181 (1986).
Potmesil, M., Camptothecin: from bench research to hospital wards.Cancer Res. 54, 1431–1439 (1994).
Potmesil, M. and Pinedo, H.,Camptothecins: new anticancer agents, CRC Press (1995).
Roth, G. N., Chandra, A., Nair, M. G., Novel bioactivities ofCurcuma longa constituents.J, Nat, Prod., 61, 542–545 (1998).
Schneider, E., Hsiang, Y. H., and Liu, L., DNA topoisomerases as anticancer drug targets.Adv. Pharmacol., 21, 149–183 (1990).
Shirng, E., B. and Gottlieb, D., Methods for the characterization ofStreptomyces species.Int. J. Syst. Bacteriol., 16, 313–340 (1966).
Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., and Kaufmann, S. H., The current status of camptothecin analogues as antitumor agents.J. Natl. Cancer Inst., 85, 271–291 (1993).
Tamura, H., Lkegami, Y., Ono, K., Sekimizu, K., and Andoh, T., Acidic phospholipids directly inhibit DNA binding of mamalian DNA topoisomerase I.FEBS Lett, 261, 151–154 (1990).
Umekawa, H., Tamiya-Koizumi, K., Takagi, E., Ariga, H., Kojima, K., and Yoshida, S., Phospholipid modulatesin vitro replication of autonomous replicating sequence from human cells.J. Biochem., 104, 333–336 (1988).
Wang, J. C., Recent studies of DNA topoisomerses.Biochim. Biophys. Acta, 904, 1–9 (1987).
Wang, J. C., Johnson, R. K., Hecht, S. M., Inhibition of topoisomerase I function by nitidien and fagaronine.Chem. Res. Toxicol., 6, 813–818 (1993).
Wang, J. C., DNA topoisomerases.Annu. Rev. Biochem., 65, 635–692 (1996).
Wijekoon, W. M. D., Ayanoglu, E., and Djerassi, C., Phospholipid studies of marine organisms 9: New brominated demospongic acids from the phospholipids of twoPetrosia species.Tetrahedron, 25, 3285–3288 (1984).
Williams, S. T., Goodfellow, M., Wellingen, E. M. H., Vickers, J. C., Alderson, G., Sneath, P. H. A., Sackin, M., and Mortimer, A., M., A probability matrix for identification of someStreptomyces.J. Gen. Microbiol., 129, 1815–1830 (1983).
Yamashita, Y., Kawada, S. Z., Fujii, N., and Nakano, H., Induction of mamalian DNA topoisomerase I and II mediated cleavage by saintopin, a new antitumor agent from fungus.Biochemistry, 30, 5838–5845 (1991).
Yoshikazu, S., Tsukahara, S., Oh-hara, T., Isoe, T., and Tsuruo, T., Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell line as determined by a monoclonal antibody.J. Cancer Research, 50, 6925–2930 (1990).
Zahir, A., Jossang, A., Bodo, B., DNA topoisomerase I inhibitors: cytotoxic flavones fromLethedon tannaensis.J. Nat. Prod., 59, 701–703 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, H.K., Lee, DS., Lim, J. et al. Topoisomerase i inhibitors from theStreptomyces sp. strain KM86-9B isolated from a marine sponge. Arch. Pharm. Res. 21, 729–733 (1998). https://doi.org/10.1007/BF02976766
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976766